'''Mycoplasma pneumoniae''' is a very small
bacterium, in the class
Mollicutes. This class of organisms lack a
peptidoglycan cell wall present on all other
firmicute bacteria. Instead, it has a
cell membrane which incorporates
sterol compounds, similar to
eukaryotic cells. It obtains these sterols from the host serum, allowing it to retain a simple structure. Lacking a
cell wall, these organisms are resistant to the effects of
penicillins and other beta-lactam antibiotics, which act by disrupting the bacterial cell wall.
''M. pneumoniae'' has one of the smallest
genomes known, with 816 kilo
base pairs (kbs). Its genome and
proteome has been fully characterized. It uses some unique genetic code, making its code more similar to mitochondria than to other bacteria. Thus it is said that ''Mycoplasma pneumoniae'' has a degenerate genome. It lacks the cellular machinery for making many essential compounds, including new
purines and
pyrimidines. It also has no
tri-carboxylic acid cycle and an incomplete
electron transport chain. Because of this, it is an obligate
parasite. No mycoplasma is found free-living.
''M. pneumoniae'' is spread through
respiratory droplet transmission. Once attached to the mucosa of a host organism, ''M. pneumonia'' extracts nutrients, grows and reproduces by
binary fission. Attachment sites include the upper and lower respiratory tract, causing
pharyngitis,
bronchitis and
pneumonia. The infection caused by this bacterium is called
atypical pneumonia because of its protracted course and lack of sputum production and wealth of extra-pulmonary symptoms. Chronic mycoplasma infections have been implicated in the pathogenesis of
rheumatoid arthritis and other rheumatological diseases.
''M. pneumoniae'' infections can be differentiated from other types of pneumonia by the relatively slow progression of symptoms, a positive blood test for cold-hemagglutinins in 50-70% of patients after 10 days of infection, lack of bacteria in a gram stained sputum sample, and a lack of growth on blood agar.
Mycoplasma atypical pneumonia can be complicated by
Stevens-Johnson syndrome,
hemolytic anemia,
encephalitis or
Guillain-Barré syndrome.
Second generation
macrolide antibiotics,
doxycycline and second generation
quinolones are effective treatments. Disease from mycoplasma is usually mild to moderate in severity.
M. pneumoniae was historically called "Eaton's agent"
[1] due to the fact that it is grown on
Eaton's agar.
External links
★
''Mycoplasma pneumoniae'' genome